Cell Engineering and Molecular Pharming for Biopharmaceuticals

Abdullah, MA (2008) Cell Engineering and Molecular Pharming for Biopharmaceuticals. [Citation Index Journal]

[img] PDF (The Open Medicinal Chemistry Journal, 2008, 2, 49-61)
Restricted to Registered users only



Biopharmaceuticals are often produced by recombinant E. coli or mammalian cell lines. This is usually achieved by the introduction of a gene or cDNA coding for the protein of interest into a well-characterized strain of producer cells. Naturally, each recombinant production system has its own unique advantages and disadvantages. This paper examines the current practices, developments, and future trends in the production of biopharmaceuticals. Platform technologies for rapid screening and analyses of biosystems are reviewed. Strategies to improve productivity via metabolic and integrated engineering are also highlighted.

Item Type:Citation Index Journal
Subjects:R Medicine > R Medicine (General)
Departments / MOR / COE:Research Institutes > Institute for Health Analytics
ID Code:6387
Deposited By: Dr Mohd Azmuddin Abdullah
Deposited On:05 Sep 2011 00:38
Last Modified:19 Jan 2017 08:26

Repository Staff Only: item control page

Document Downloads

More statistics for this item...